What is the PHAR stock price prediction for next 2 weeks?

According to our price prediction algorithm,Pharming Group N.V. (PHAR) price will be around $11.50 in the next 2 weeks. This means it will increase by 0.38656195462477994 from the last closing price. This prediction may vary from other time period filters for PHAR stock.

What can be the highest Possible price of PHAR stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, PHAR can achieve the highest price of $12.24 which is 6.810691290993565 higher than last closing price. This prediction may vary from other time period filters for PHAR stock.

What can be the lowest Possible price of PHAR stock in next 2 weeks?

As per the forecast and algorithmic analysis, PHAR stock price can be as low as $10.77 which is -6.0192110677187465 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for PHAR stock.

Will PHAR stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that PHAR stock will gain0.38656195462477994 in the next 2 weeks. This prediction may vary from other time period filters for PHAR stock.

What is PHAR stock last closing price?

Last closing price of PHAR stock was $11.23.

What is PHAR stock price prediction?

PHAR stock price prediction means predicting the future closing prices of PHAR stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of PHAR stock in a certain time period.

How we predict PHAR stock future prices?

If you are searching for PHAR stock forecast, analysis or price prediction, then you might be wondering what Pharming Group N.V. (PHAR) will do in the future. Our PHAR price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This PHAR price prediction will likely answer most of your questions.

How frequent we update PHAR stock predictions?

We are updating the forecasts for the PHAR stock on daily basis.

Is using ML forecasting for PHAR stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for PHAR stock same for all the time periods?

No, the prediction for PHAR stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Pharming Group N.V. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$11.23-5.23%Since 2 Weeks

Predicted Price$11.500.39%For 2 Weeks

Upper Predicted Price$12.246.81%For 2 Weeks

Lower Predicted Price$10.77-6.02%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of PHAR will rise by +0.39% over the next 2 Weeks and hit $11.50 by Thursday, September 17, 2026. In that time frame, PHAR's share price is expected to range between $10.77 and $12.24.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Sep 17, 2026	10.77	11.50	12.24
Sep 16, 2026	10.76	11.53	12.30
Sep 15, 2026	10.79	11.54	12.33
Sep 14, 2026	10.60	11.32	12.05
Sep 11, 2026	10.38	11.21	11.96
Sep 10, 2026	10.66	11.41	12.22
Sep 9, 2026	10.62	11.44	12.18
Sep 8, 2026	10.73	11.44	12.21
Sep 7, 2026	10.46	11.23	12.04
Sep 4, 2026	10.27	11.12	11.80

PHAR shares fell -2.01% in Friday, September 4, 2026's trading session, dropping from a previous close of $11.46 to move at $11.23. The stock demonstrated notable intraday movement (see PHAR's key stats for a full breakdown), fluctuating between $11.16 and $11.54, a +3.41% trading range. While recent weeks have seen some volatility, PHAR has managed to secure a -2.01% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 5.54K shares changing hands, 193 more than the previous session. This amounted to $62.25K in total market activity.

Will PHAR Continue Its Upward Trend?

According to analyst ratings and projections for PHAR, Pharming Group N.V. shares are anticipated to increase by +8.26%, potentially reaching $12.24 per share by September 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for PHAR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the PHAR stock forecast, now is a good time to buy PHAR stock because its current trading price is -2.38% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on PHAR covering social and institutional perspectives.

PHAR Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into PHAR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.80% to 43.47%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.35%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.60%, maintains a neutral outlook for the long term. Insights into PHAR's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Pharming Group NV Short-Term Forecasts

PHAR Forecast For Next 5 Days

Our algorithm anticipates Pharming Group NV (PHAR) stock could hit $12.85 by Sep 11, 2026. This represents a +14.46% fall from today's price, following a -4.58% change over the past five days.

PHAR Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Pharming Group N.V. (PHAR) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $11.84, which would mean a +5.43% increase from the current price of $11.23. Projections for this period range from a high of $14.16 to a low of $9.04.

PHAR Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Pharming Group NV's price over the next three months point to a rise. PHAR stock is expected to peak at $29.27 on Nov 26, 2026 after potentially dipping to $19.92 on Oct 16, 2026. On average, PHAR is likely to trade around $24.28 in the coming 90 days.

Pharming Group NV Stock Forecast 2025

Based on our predictive models, Pharming Group NV (PHAR) is expected to trade between $19.92 and $29.27 throughout 2026. This would result in an average price of $25.12, potentially offering investors a +123.69% return from current levels.

Pharming Group N.V. Monthly Forecast 2026–2027

September 2026

According to our latest forecast models, Pharming Group N.V. (PHAR) is positioned to show a strong performance in September 2026. The price is predicted to move between $22.22 and $25.49, settling at an average of $24.22. This could translate to a +115.67% gain.

October 2026

Based on current market signals, Pharming Group N.V. is projected to trend october 2026. We forecast a trading range from $19.92 to $23.94, with a likely average price of $21.57. Investors could expect a potential return of +92.07%.

November 2026

Our predictive algorithms indicate Pharming Group N.V. stock may see a shift in November 2026. The expected range spans $22.56–$29.27, with an average target of $26.45. This represents a positive outlook and a possible gain of +135.53%.

December 2026

Analyzing established trends, Pharming Group N.V. looks set to move in December 2026. Projections place the stock between $27.53 and $28.62, averaging around $28.04. This suggests a +149.69% gain from current levels.

January 2027

Market indicators suggest Pharming Group N.V. could experience notable changes during January 2027. Prices could fluctuate within $27.77 to $30.33, with a midpoint forecast of $29.33. The stock might deliver a +161.18% gain.

February 2027

Forecasting for February 2027, models estimate that Pharming Group N.V. may undergo key fluctuations. If trends hold, the stock might trade between $26.14 and $30.52, averaging $28.35. This signals a positive trajectory with potential returns around +152.45%.

March 2027

According to our latest forecast models, Pharming Group N.V. (PHAR) is positioned to show a strong performance in March 2027. The price is predicted to move between $24.00 and $26.17, settling at an average of $25.09. This could translate to a +123.42% gain.

April 2027

Based on current market signals, Pharming Group N.V. is projected to trend april 2027. We forecast a trading range from $25.56 to $29.31, with a likely average price of $27.51. Investors could expect a potential return of +144.97%.

May 2027

Our predictive algorithms indicate Pharming Group N.V. stock may see a shift in May 2027. The expected range spans $19.51–$25.13, with an average target of $21.97. This represents a positive outlook and a possible gain of +95.64%.

June 2027

Analyzing established trends, Pharming Group N.V. looks set to move in June 2027. Projections place the stock between $18.49 and $20.46, averaging around $19.28. This suggests a +71.68% gain from current levels.

July 2027

Market indicators suggest Pharming Group N.V. could experience notable changes during July 2027. Prices could fluctuate within $16.98 to $21.79, with a midpoint forecast of $20.09. The stock might deliver a +78.90% gain.

August 2027

Forecasting for August 2027, models estimate that Pharming Group N.V. may undergo key fluctuations. If trends hold, the stock might trade between $15.84 and $21.38, averaging $17.99. This signals a positive trajectory with potential returns around +60.20%.

September 2027

According to our latest forecast models, Pharming Group N.V. (PHAR) is positioned to show a strong performance in September 2027. The price is predicted to move between $21.12 and $22.32, settling at an average of $21.74. This could translate to a +93.59% gain.

PHAR's history of dividends and stock splits also plays a role in long-term investor confidence.